Plasma kinetics of a cholesterol-rich microemulsion (LDE) in patients with Hodgkin's and non-Hodgkin's lymphoma and a preliminary study on the toxicity of etoposide associated with LDE

Cancer Chemotherapy and Pharmacology

Volumn 57, Issue 5, 2006, Pages 624-630

  Pinheiro, Ketlin V ^a   Hungria, Vania T M ^b   Ficker, Elisabeth S ^a   Valduga, Claudete J ^a   Mesquita, Carlos H ^a   Maranhão, Raul C ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FACULDADE DE CIÊNCIAS MÉDICAS DA SANTA CASA DE SÃO PAULO   (Brazil)

Author keywords

Cholesterol; Drug targeting; Etoposide; Lipid emulsions; Lymphoma treatment; Nanoparticles

Indexed keywords

CHOLESTEROL; CHOLESTEROL ESTER; CHOLESTEROL OLEATE; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; GEMCITABINE; IFOSFAMIDE; PHOSPHATIDYLCHOLINE; PREDNISONE; TRIOLEIN; TRITIUM; VINCRISTINE;

ABSENCE OF SIDE EFFECTS; ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CANCER RELAPSE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG CLEARANCE; DRUG HYPERSENSITIVITY; FEMALE; GASTROINTESTINAL TOXICITY; HODGKIN DISEASE; HUMAN; ISOTOPE LABELING; LIVER TOXICITY; LUNG TOXICITY; MALE; MICROEMULSION; NEPHROTOXICITY; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; SEQUENTIAL ANALYSIS; VASOMOTOR DISORDER;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CHOLESTEROL ESTERS; CHOLESTEROL, LDL; DRUG CARRIERS; EMULSIONS; ETOPOSIDE; FEMALE; HODGKIN DISEASE; HUMANS; KINETICS; LYMPHOMA, NON-HODGKIN; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; PILOT PROJECTS; RECEPTORS, LDL;

EID: 32544437171     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-005-0090-8     Document Type: Article

References (36)

1. Ades A, Carvalho JP, Graziani SR, Amancio RF, Souen JS, Pinotti JA, Maranhão RC (2001) Uptake of a cholesterol-rich emulsion by neoplastic ovarian tissues. Gynecol Oncol 82(1):84-87
2. Alexopoulos CG, Pournaras S, Vaslamatzis M, Avgerinos A, Raptis S (1992) Changes in serum lipids and lipoprotein in cancer patients during chemotherapy. Cancer Chemother Pharmacol 30:412-416
3. Blackman JD, Cabana VG, Mazzone T (1993) The acute-phase response and associated lipoprotein abnormalities accompanying lymphoma. J Intern Med 233(2):201-204
4. Brown MS, Goldstein JL (1976) Receptor-mediated control of cholesterol metabolism. Study of human mutants has disclosed how cells regulate a substance that is both vital and lethal. Science 191:150-154
5. Brown MS, Goldstein JL (1986) A receptor-mediated pathway for cholesterol homeostasis. Science 232:34-47
6. Cheson BD, Horning SJ, Coiffier B, Shipp MA, Fisher RI, Connors JM, Lister TA, Vose J, Grillo-Lopez A, Hagenbeek A, Cabanillas F, Klippensten D, Hiddemann W, Castellino R, Harris NL, Armitage JO, Carter W, Hoppe R, Canellos GP (1999) Report of an international workshop to standardize response criteria for non-Hodgkin's lymphoma. J Clin Oncol 17:1244-1253
7. Friedewald WT, Levy RI, Fredrickison DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without the use of the preparative ultracentrifugue. Clin Chem 18:499-502
8. Ginsburg GS, Small DM, Atkinson D (1982) Microemulsions of phospholipids and cholesterol esters. J Biol Chem 257:8216-8227
9. Gonçalves RP, Hungria VT, Chiattone CS, Pozzi DB, Maranhão RC (2002) Metabolism of chylomicron-like emulsions in patients with Hodgkin's and with non-Hodgkin's lymphoma. Leuk Res 27:147-153
10. Graziani SR, Igreja FA, Hegg R, Meneghetti C, Brandizzi LI, Barboza R, Amâncio RF, Pinotti JA, Maranhão RC (2002) Uptake of a cholesterol-rich emulsion by breast cancer. Gynecol Oncol 85:493-497
11. Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, Lister TA, Bloomfield CD (2000) The World Health Organization classification of neoplasms of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. Hematol J 1(1):53-66
12. Hirata RD, Hirata MH, Mesquita CH, Cesar TB, Maranhao RC (1999) Effects of apolipoprotein B-100 on the metabolism of a lipid microemulsion model in rats. Biochim Biophys Acta 1437:3-62
13. Ho YK, Brown MS, Bilheimer DW, Goldstein JL (1976) Regulation of low density lipoprotein receptor activity in freshly isolated human lymphocytes. J Clin Invest 58:1465-1474
14. Ho YK, Smith RG, Brown MS, Goldstein JL (1978) Low density lipoprotein (LDL) receptor activity in human acute myelogenous leukemia cells. Blood 52:1099-1114
15. Hungria VTM, Latrilha MC, Rodrigues DG, Bydlowski SP, Chiattone CS, Maranhão RC (2004) Metabolism of a cholesterol-rich microemulsion (LDE) in patients with multiple myeloma and a preliminary clinical study of LDE as a drug vehicle for the treatment of the disease. Cancer Chemother Pharmacol 53(1):51-60
16. Iribarren C, Reed DM, Yano K (1995) Low serum cholesterol and mortality. Which is the cause and which is the effect? Circulation 92:2396-2403
17. Lewis GF, Lamarche B, Uffelman KD, Heatherington AC, Honig MA, Szeto LW, Barrett PH (1997) Clearance of postprandial and lipolytically modified human HDL in rabbits and rats. J Lipid Res 38(9):1771-1778
18. Lundberg B (1994) The solubilization of lipophilic derivates of podophyllotoxins in sub-micron sized lipid emulsions and their cytotoxic activity against cancer cells in culture. Int J Pharm 109:73-81
19. Maranhão RC, Cesar TB, Pedroso MTB, Hirata MH, Mesquita CH (1993) Metabolic behavior in rats of a non-protein microemulsion resembling LDL. Lipids 28:691-696
20. Maranhão RC, Garicochea B, Silva EL, Dorlhiac-Llacer P, Cadena SMS, Coelho IJC, Meneghetti JC, Pileggi FJC, Chamone DAF (1994) Plasma kinetics and biodistribution of a lipid emulsion resembling low-density lipoprotein in patients with acute leukemia. Cancer Res 54:4660-4666
21. Maranhão RC, Graziani SR, Yamaguchi N, Melo RF, Latrilha MC, Rodrigues DG, Couto RD, Schreier S, Buzaid AC (2002) Association of carmustine with a lipid emulsion: in vitro, in vivo and preliminary studies in cancer patients. Cancer Chemother Pharmacol 49:487-498
22. Maranhão RC, Roland IA, Toffoletto O, Ramires JA, Goncalves RP, Mesquita CH, Pileggi F (1997) Plasma kinetic behavior in hyperlipidemic subjects of a lipidic microemulsion that binds to low density lipoprotein receptors. Lipids 32:627-633
23. 137 C transfer rates in marine organisms and dose in man. J Radioan Nucl Chem 232:233-236
24. Matthews CME (1957) The theory of tracer experiments with 131I-labeled plasma proteins. Phys Med Biol 2:36-41
25. Muller CP, Trilling B, Steinke B (1992) The prognostic significance of total serum cholesterol in patients with Hodgkin's disease. Cancer 69(4):1042-1046
26. Pandolfino J, Hakimian D, Rademaker AW, Tallman MS (1997) Hypocholesterolemia in hairy cell leukemia: a marker for proliferative activity. Am J Hematol 55:129-133
27. Pinto LB, Wajngarten M, Silva EL, Vinagre CC, Maranhão RC (2001) Plasma kinetic of a cholesterol-rich emulsion in young, middle-aged, and elderly subjects. Lipids 36:1307-1311
28. Rodrigues DG, Covolan CC, Coradi ST, Barboza R, Maranhão RC (2002) Use a cholesterol-rich emulsion that binds to low-density lipoprotein receptors as a vehicle for paclitaxel. J Pharm Pharmacol 54:765-772
29. Santos R, Chacra A, Vinagre C, Morikawa A, Silva V, Ficker E, Martinez T, Maranhão R (2003) Plasma kinetics of a cholesterol-rich emulsion that binds to LDL receptors in familial hipercholesterolemia: effects of statins. Atherosclerosis 4(Suppl):241
30. Santos RD, Hueb W, Oliveira AA, Ramires JA, Maranhao RC (2003) Plasma kinetics of a cholesterol-rich emulsion in subjects with or without coronary artery disease. J Lipid Res 44:464-469
31. Sowby FS Radiation protection. In: Limits for intakes of radionuclides by workers. IRCP publication 30. Part I. Pergamon, Oxford
32. Spiegel RJ, Schaefer EJ, Magrath IT, Edwards BK (1982) Plasma lipid alterations in leukemia and lymphoma. Am J Med 72:775-782
33. Teixeira RS, Curi R, Maranhão RC (2004) Effects on walker 256 tumour of carmustine associated with a cholesterol-rich microemulsion (LDE). J Pharm Pharmacol 56(7):909-914
34. Valduga CJ, Fernandes DC, Lo Prete AC, Azevedo CHM, Rodrigues DG, Maranhão RC (2003) Use of a cholesterol-rich microemulsion that binds to low-density lipoprotein receptors as vehicle for etoposide. J Pharm Pharmacol 55(12):1615-1622
35. Yen CF, Kalunta CI, Chen FS, Kaptein JS, Lin CK, Lad PM (1994) Flow cytometric evaluation of LDL receptors using DiI-LDL uptake and its application to B and T lymphocytic cell lines. J Immunol Methods 177(1-2):55-67
36. Yen CF, Kalunta CI, Chen FS, Kaptein JS, Lin CK, Lad PM (1995) Regulation of low-density lipoprotein receptors and assessment of their functional role in Burkitt's lymphoma cells. Biochim Biophys Acta 1257(1):47-57